BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

Clinical trial NCT02650804 · COMPLETED

Trial details

NCT number: NCT02650804
Sponsor: BPGbio
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2016-07-06
Primary completion: 2019-06-11
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.